Biomarkers of nephrotoxic acute kidney injury.

[1]  H. Taniguchi,et al.  Renal L-type fatty acid--binding protein in acute ischemic injury. , 2007, Journal of the American Society of Nephrology : JASN.

[2]  J. Bonventre,et al.  Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. , 2007, Kidney international.

[3]  C. Edelstein,et al.  Cisplatin-Induced Acute Renal Failure Is Associated with an Increase in the Cytokines Interleukin (IL)-1β, IL-18, IL-6, and Neutrophil Infiltration in the Kidney , 2007, Journal of Pharmacology and Experimental Therapeutics.

[4]  Harald Mischak,et al.  Advances in urinary proteome analysis and biomarker discovery. , 2007, Journal of the American Society of Nephrology : JASN.

[5]  B. Molitoris,et al.  The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. , 2007, Kidney international.

[6]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[7]  J. Boldt,et al.  Kidney-specific proteins: markers for detection of renal dysfunction after cardiac surgery? , 2007 .

[8]  R. Star,et al.  Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. , 2006, Kidney international.

[9]  Joseph V Bonventre,et al.  Mechanistic biomarkers for cytotoxic acute kidney injury , 2006, Expert opinion on drug metabolism & toxicology.

[10]  Mihwa Kim,et al.  Association between Increases in Urinary Neutrophil Gelatinase–associated Lipocalin and Acute Renal Dysfunction after Adult Cardiac Surgery , 2006, Anesthesiology.

[11]  F. Di Maggio,et al.  BIOMARKERS OF ACUTE RENAL INJURY AND RENAL FAILURE , 2006, Shock.

[12]  A. Arısoy,et al.  Acute effects of gentamicin on glomerular and tubular functions in preterm neonates , 2006, Pediatric Nephrology.

[13]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[14]  M. Mitsnefes,et al.  Kidney NGAL is a novel early marker of acute injury following transplantation , 2006, Pediatric Nephrology.

[15]  J. Dear,et al.  Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. , 2006, Kidney international.

[16]  R. Beyer,et al.  Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  M. Yamanouchi,et al.  Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease , 2006, Molecular and Cellular Biochemistry.

[18]  K. Node,et al.  Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  Joseph V Bonventre,et al.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.

[20]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[21]  L. Price,et al.  Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[22]  I. Ebihara,et al.  Urinary Liver-Type Fatty Acid-Binding Protein: Discrimination between IgA Nephropathy and Thin Basement Membrane Nephropathy , 2005, American Journal of Nephrology.

[23]  Marek Ancukiewicz,et al.  Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  J. Norenberg,et al.  Assessment of Effective Renal Plasma Flow, Enzymuria, and Cytokine Release in Healthy Volunteers Receiving a Single Dose of Amphotericin B Desoxycholate , 2005, Antimicrobial Agents and Chemotherapy.

[25]  R. Bellomo,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[26]  Susan G. Emeigh Hart,et al.  Assessment of renal injury in vivo. , 2005 .

[27]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[28]  Mingyu Liang,et al.  Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. , 2005, American journal of physiology. Renal physiology.

[29]  Qing Ma,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.

[30]  P. Nickerson,et al.  Proteomic‐Based Identification of Cleaved Urinary β2‐microglobulin as a Potential Marker for Acute Tubular Injury in Renal Allografts , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  Tadashi Yamamoto,et al.  Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules , 2005, Laboratory Investigation.

[32]  Tadashi Yamamoto,et al.  Osteopontin expression in acute renal allograft rejection. , 2005, Kidney international.

[33]  W. Hermens,et al.  Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[34]  J. Delanghe,et al.  Alpha 1-microglobulin: clinical laboratory aspects and applications. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[35]  S. Gang,et al.  Enzymuria pattern in early post renal transplant period: Diagnostic usefulness in graft dysfunction , 2004, Indian Journal of Clinical Biochemistry.

[36]  F. Gejyo,et al.  Expression of Osteopontin in Cisplatin-Induced Tubular Injury , 2004, Nephron Experimental Nephrology.

[37]  J. Lácha,et al.  INTERLEUKIN 18 (IL-18) UPREGULATION IN ACUTE REJECTION OF KIDNEY ALLOGRAFT , 2004 .

[38]  L. Bachmann,et al.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.

[39]  K. Mori,et al.  Neutrophil Gelatinase-Associated Lipocalin: A Novel Early Urinary Biomarker for Cisplatin Nephrotoxicity , 2004, American Journal of Nephrology.

[40]  A. Kribben,et al.  Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. , 2004, Clinical chemistry.

[41]  C. Edelstein,et al.  Urinary interleukin-18 is a marker of human acute tubular necrosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  M. Sehested,et al.  Neutrophil Gelatinase-Associated Lipocalin Is Up-Regulated in Human Epithelial Cells by IL-1β, but Not by TNF-α 1 , 2003, The Journal of Immunology.

[43]  N. Soomro,et al.  Do tissue damage biomarkers used to assess machine-perfused NHBD kidneys predict long-term renal function post-transplant? , 2003, Clinica chimica acta; international journal of clinical chemistry.

[44]  G. D'Amico,et al.  Urinary protein and enzyme excretion as markers of tubular damage , 2003, Current opinion in nephrology and hypertension.

[45]  M. Mitsnefes,et al.  Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. , 2003, Journal of the American Society of Nephrology : JASN.

[46]  P. Houillier,et al.  Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  M. Yamanouchi,et al.  Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. , 2003, The Journal of laboratory and clinical medicine.

[48]  T. J. Morgan,et al.  Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  J. Wieslander,et al.  Increased circulating levels of proteinase 3 in patients with anti‐neutrophilic cytoplasmic autoantibodies‐associated systemic vasculitis in remission , 2003, Clinical and experimental immunology.

[50]  R. Star,et al.  Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. , 2002, Kidney international.

[51]  G. D'Amico,et al.  Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  G. Kootstra,et al.  Functional relationship of α-glutathione S-transferase and glutathione S-transferase activity in machine-preserved non-heart-beating donor kidneys , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[53]  J. Bonventre,et al.  Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration* , 2002, The Journal of Biological Chemistry.

[54]  C. Edelstein,et al.  Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. , 2002, The Journal of clinical investigation.

[55]  A. Gotoh,et al.  Measurement of cystatin-C and creatinine in urine. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[56]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[57]  C. Snowden,et al.  Renal tubular injury after infrarenal aortic aneurysm repair. , 2002, Journal of cardiothoracic and vascular anesthesia.

[58]  S. Hou,et al.  Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  M. Kakei,et al.  INCREASED URINARY EXCRETION OF N-ACETYLGLUCOSAMINIDASE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE , 2002, Renal failure.

[60]  D. Bates,et al.  Guided medication dosing for inpatients with renal insufficiency. , 2001, JAMA.

[61]  S. Swain,et al.  Interleukin 18 , 2001, The Journal of experimental medicine.

[62]  Fengli Zhang,et al.  Binding of 13-HODE and 15-HETE to Phospholipid Bilayers, Albumin, and Intracellular Fatty Acid Binding Proteins , 2001, The Journal of Biological Chemistry.

[63]  M. Lucia,et al.  Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. , 2001, The Journal of clinical investigation.

[64]  S. Dauwe,et al.  Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[65]  F. Gejyo,et al.  Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process. , 2001, Kidney international.

[66]  A. Harken,et al.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[67]  W. Hiddemann,et al.  Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotection. , 2000, Anticancer research.

[68]  H. Nizze,et al.  Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[69]  C. Sprung,et al.  Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score , 2000, Intensive Care Medicine.

[70]  M. Underwood,et al.  On-pump versus off-pump coronary revascularization: evaluation of renal function. , 1999, The Annals of thoracic surgery.

[71]  M. D. de Broe,et al.  Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. , 1999, Kidney international.

[72]  G. Schlüter,et al.  Urinary antigens as markers of papillary toxicity. II: Application of monoclonal antibodies for the determination of papillary antigens in rat urine , 1999, Archives of Toxicology.

[73]  M. Goldberg,et al.  Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. , 1999, Anesthesia and analgesia.

[74]  M. Jadoul,et al.  Beta-2 microglobulin in renal disease. , 1998, Journal of the American Society of Nephrology : JASN.

[75]  P. Cochat,et al.  Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma , 1998, Pediatric Nephrology.

[76]  J Pascual,et al.  The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. , 1998, Kidney international. Supplement.

[77]  K E Hammermeister,et al.  Independent association between acute renal failure and mortality following cardiac surgery. , 1998, The American journal of medicine.

[78]  Joseph V. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.

[79]  J. Cowland,et al.  Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. , 1997, Genomics.

[80]  R. Kamen,et al.  Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production , 1997, Nature.

[81]  K. Nath,et al.  Temporal induction of clusterin in cisplatin nephrotoxicity. , 1997, Journal of the American Society of Nephrology : JASN.

[82]  E. Kharasch,et al.  Role of Renal Cysteine Conjugate beta‐Lyase in the Mechanism of Compound A Nephrotoxicity in Rats , 1997, Anesthesiology.

[83]  R. Weiskopf,et al.  Nephrotoxicity of Sevoflurane Versus Desflurane Anesthesia in Volunteers , 1997, Anesthesia and analgesia.

[84]  R. Chevalier.  Growth factors and apoptosis in neonatal ureteral obstruction. , 1996, Journal of the American Society of Nephrology : JASN.

[85]  B. Nielsen,et al.  Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. , 1996, Gut.

[86]  G. Hempelmann,et al.  [Tamm-Horsfall protein, alpha-1- and beta-2-microglobulin as kidney function markers in heart surgery]. , 1995, Der Anaesthesist.

[87]  G. Hempelmann,et al.  Tamm-Horsfall-Protein, α 1- und β 2-Mikroglobulin als Nierenfunktionsmarker in der Herzchirurgie , 1995, Der Anaesthesist.

[88]  P. Venge,et al.  Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. , 1995, Scandinavian journal of clinical and laboratory investigation.

[89]  B. Nielsen,et al.  Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. , 1995, Blood.

[90]  J. Bonventre,et al.  Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. , 1994, The Journal of clinical investigation.

[91]  T. Saruta,et al.  Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction. , 1993, Clinical science.

[92]  J. Veerkamp,et al.  Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. , 1992, The Biochemical journal.

[93]  Jerome J. Schentag,et al.  Renal Tubular Enzyme Effects of Clarithromycin in Comparison with Gentamicin and Placebo in Volunteers , 1992, Drug safety.

[94]  M. Paller,et al.  Differential gene expression in the recovery from ischemic renal injury. , 1991, Kidney international.

[95]  J. Veerkamp,et al.  Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. , 1991, The Biochemical journal.

[96]  G. Haycock,et al.  Prediction of acute renal failure after birth asphyxia. , 1990, Archives of disease in childhood.

[97]  H. Mashiba,et al.  Urinary N-Acetyl-β-D-Glucosaminidase in the Patients with Hyperthyroidism , 1989 .

[98]  R. Rubin,et al.  Noninvasive renal diagnostic studies. , 1988, Clinics in laboratory medicine.

[99]  M. Rybak,et al.  Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin , 1987, Antimicrobial Agents and Chemotherapy.

[100]  A. Vyskočil,et al.  Assessment of urinary retinol-binding protein as an index of proximal tubular injury. , 1987, Clinical chemistry.

[101]  P. Mueller,et al.  Stabilization of alanine aminopeptidase, gamma glutamyltranspeptidase, and N-acetyl-Β-D-glucosaminidase activity in normal urines , 1986, Archives of environmental contamination and toxicology.

[102]  J. Cabezas,et al.  Inhibition of A and B N-acetyl-beta-D-glucosaminidase urinary isoenzymes by urea. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[103]  B. Myers,et al.  Course of acute renal failure studied by a model of creatinine kinetics. , 1985, Kidney international.

[104]  I. Maclennan,et al.  Alpha-1-microglobulin: an indicator protein for renal tubular function. , 1983, Journal of clinical pathology.

[105]  J. Cohen,et al.  Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.

[106]  K. Jung,et al.  Influence of pH on the activity of enzymes in urine at 37 degrees C. , 1982, Clinical chemistry.

[107]  Jerome J. Schentag,et al.  Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides. , 1980, Kidney international.

[108]  Ronald P. Brown,et al.  Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[109]  B. Jaber,et al.  Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. , 2007, Journal of the American Society of Nephrology : JASN.

[110]  A. Durrbach,et al.  Urinary cystatin C as a specific marker of tubular dysfunction , 2006, Clinical chemistry and laboratory medicine.

[111]  T. Luukkaala,et al.  Tubular proteinuria in pre-term and full-term infants , 2006, Pediatric Nephrology.

[112]  S. Goldstein,et al.  Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[113]  Susan G Emeigh Hart,et al.  Assessment of renal injury in vivo. , 2005, Journal of pharmacological and toxicological methods.

[114]  M. Pelsers,et al.  Use of two biomarkers of renal ischemia to assess machine-perfused non-heart-beating donor kidneys. , 2003, Clinical chemistry.

[115]  J. Bonventre,et al.  Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .

[116]  M. Iqbal,et al.  Urinary N-acetyl-beta-D-glucosaminidase in rheumatoid arthritis. , 1998, Experimental & molecular medicine.

[117]  E. Honkanen.  [Treatment of acute renal failure]. , 1998, Duodecim; laaketieteellinen aikakauskirja.

[118]  M Kurimoto,et al.  Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. , 1997, Science.

[119]  R. Kamen,et al.  Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. , 1997, Nature.

[120]  Nancy Edwards,et al.  Refinement of the Medicare Diagnosis-Related Groups to Incorporate a Measure of Severity , 1994, Health care financing review.

[121]  M. Yaqoob,et al.  Human urinary intestinal alkaline phosphatase as an indicator of S3-segment-specific alterations in incipient diabetic nephropathy. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[122]  S. Chew,et al.  Urinary enzymes in acute renal failure. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[123]  Joseph T. DiPiro,et al.  Pharmacotherapy: A pathophysiologic approach , 1992 .

[124]  K. Jung,et al.  Quality control material for activity determinations of urinary enzymes. , 1988, Clinical biochemistry.

[125]  J. Mallol,et al.  Beta-2-microglobulin as an index of renal function after cardiopulmonary bypass surgery in children. , 1988, Child nephrology and urology.

[126]  A K Mortagy,et al.  Risk factors and outcome of hospital-acquired acute renal failure (clinical epidemiologic study). , 1988, The Journal of the Egyptian Public Health Association.

[127]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.